United States Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033

United States Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A11240

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
    2.4    Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   United States Gene Therapy Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   United States Gene Therapy Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   United States Gene Therapy Market - Breakup by Gene Type
    6.1    Antigen
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Forecast (2025-2033)
    6.2    Cytokine
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Forecast (2025-2033)
    6.3    Tumor Suppressor
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (2019-2024)
        6.3.3 Market Forecast (2025-2033)
    6.4    Suicide Gene
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (2019-2024)
        6.4.3 Market Forecast (2025-2033)
    6.5    Deficiency
        6.5.1 Overview
        6.5.2 Historical and Current Market Trends (2019-2024)
        6.5.3 Market Forecast (2025-2033)
    6.6    Growth Factors
        6.6.1 Overview
        6.6.2 Historical and Current Market Trends (2019-2024)
        6.6.3 Market Forecast (2025-2033)
    6.7    Receptors
        6.7.1 Historical and Current Market Trends (2019-2024)
        6.7.2 Market Forecast (2025-2033) 
    6.8    Others
        6.8.1 Historical and Current Market Trends (2019-2024)
        6.8.2 Market Forecast (2025-2033)
7   United States Gene Therapy Market - Breakup by Vector Type
    7.1    Viral Vector
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)    
        7.1.3 Key Segment
    7.1.3.1 Adenoviruses
    7.1.3.2 Lentiviruses
    7.1.3.3 Retroviruses
    7.1.3.4 Adeno-Associated Virus
     7.1.3.5 Herpes Simplex Virus
     7.1.3.6 Poxvirus
    7.1.3.7 Vaccinia Virus
    7.1.3.8 Others
        7.1.4 Market Forecast (2025-2033)
    7.2    Non-Viral Techniques
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024) 
        7.2.3 Key Segment
    7.2.3.1 Naked and Plasmid Vectors
    7.2.3.2 Gene Gun
    7.2.3.3 Electroporation
    7.2.3.4 Lipofection
     7.2.3.5 Others
        7.2.4 Market Forecast (2025-2033)
8   United States Gene Therapy Market - Breakup by Delivery Method
    8.1    In-Vivo Gene Therapy
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Forecast (2025-2033)
    8.2    Ex-Vivo Gene Therapy
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Forecast (2025-2033)
9   United States Gene Therapy Market - Breakup by Application
    9.1    Oncological Disorders
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2019-2024)
        9.1.3 Market Forecast (2025-2033)
    9.2    Rare Diseases
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2019-2024)
        9.2.3 Market Forecast (2025-2033)
    9.3    Cardiovascular Diseases
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (2019-2024)
        9.3.3 Market Forecast (2025-2033) 
   9.4    Neurological Disorders
        9.4.1 Overview
        9.4.2 Historical and Current Market Trends (2019-2024)
        9.4.3 Market Forecast (2025-2033)
    9.5    Infectious Disease
        9.5.1 Overview
        9.5.2 Historical and Current Market Trends (2019-2024)
        9.5.3 Market Forecast (2025-2033)
    9.6    Others
        9.6.1 Historical and Current Market Trends (2019-2024)
        9.6.2 Market Forecast (2025-2033)
10   United States Gene Therapy Market – Breakup by Region 
    10.1    Northeast
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2019-2024)
        10.1.3 Market Breakup by Gene Type
        10.1.4 Market Breakup by Vector Type
        10.1.5 Market Breakup by Delivery Method
        10.1.6 Market Breakup by Application
        10.1.7 Key Players
        10.1.8 Market Forecast (2025-2033)
    10.2    Midwest
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2019-2024)
        10.2.3 Market Breakup by Gene Type
        10.2.4 Market Breakup by Vector Type
        10.2.5 Market Breakup by Delivery Method
        10.2.6 Market Breakup by Application
        10.2.7 Key Players
        10.2.8 Market Forecast (2025-2033)
    10.3    South
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (2019-2024)
        10.3.3 Market Breakup by Gene Type
        10.3.4 Market Breakup by Vector Type
        10.3.5 Market Breakup by Delivery Method
        10.3.6 Market Breakup by Application
        10.3.7 Key Players
        10.3.8 Market Forecast (2025-2033)
    10.4    West
        10.4.1 Overview
        10.4.2 Historical and Current Market Trends (2019-2024)
        10.4.3 Market Breakup by Gene Type
        10.4.4 Market Breakup by Vector Type
        10.4.5 Market Breakup by Delivery Method
        10.4.6 Market Breakup by Application
        10.4.7 Key Players
        10.4.8 Market Forecast (2025-2033)
11   United States Gene Therapy Market – Competitive Landscape
    11.1    Overview
    11.2    Market Structure
    11.3    Market Player Positioning
    11.4    Top Winning Strategies
    11.5    Competitive Dashboard
    11.6    Company Evaluation Quadrant
12   Profiles of Key Players
    12.1    Company A 
        12.1.1 Business Overview
        12.1.2 Services Offered
        12.1.3 Business Strategies
        12.1.4 SWOT Analysis
        12.1.5 Major News and Events
    12.2    Company B
        12.2.1 Business Overview
        12.2.2 Services Offered
        12.2.3 Business Strategies
        12.2.4 SWOT Analysis
        12.2.5 Major News and Events
    12.3    Company C
        12.3.1 Business Overview
        12.3.2 Services Offered
        12.3.3 Business Strategies
        12.3.4 SWOT Analysis
        12.3.5 Major News and Events
    12.4    Company D 
        12.4.1 Business Overview
        12.4.2 Services Offered
        12.4.3 Business Strategies
        12.4.4 SWOT Analysis
        12.4.5 Major News and Events
    12.5    Company E
        12.5.1 Business Overview
        12.5.2 Services Offered
        12.5.3 Business Strategies
        12.5.4 SWOT Analysis
        12.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.

13   United States Gene Therapy Market - Industry Analysis
    13.1    Drivers, Restraints, and Opportunities
        13.1.1 Overview
        13.1.2 Drivers
        13.1.3 Restraints
        13.1.4 Opportunities
    13.2    Porters Five Forces Analysis
        13.2.1 Overview
        13.2.2 Bargaining Power of Buyers
        13.2.3 Bargaining Power of Suppliers
        13.2.4 Degree of Competition
        13.2.5 Threat of New Entrants
        13.2.6 Threat of Substitutes
    13.3    Value Chain Analysis
14   Appendix

United States Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials